BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14733866)

  • 1. [Changes in the spectrum of morbidity and mortality in hospital admissions of HIV infected patients during the HAART era].
    Escolano Hortelano CM; Ramos Rincón JM; Gutiérrez Rodero F; Masiá Canuto M; Hernández Aguado I; Benito Santaleocadia C; Padilla Urrea S; Martín-Hidalgo A
    Med Clin (Barc); 2004 Jan; 122(1):1-5. PubMed ID: 14733866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
    Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
    HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.
    Llibre JM; Revollo B; Vanegas S; Lopez-Nuñez JJ; Ornelas A; Marin JM; Santos JR; Marte P; Morera M; Zuluaga P; Tor J; Clotet B
    Scand J Infect Dis; 2013 Aug; 45(8):635-44. PubMed ID: 23547568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection.
    Meijide H; Mena Á; Rodríguez-Osorio I; Pértega S; Castro-Iglesias Á; Rodríguez-Martínez G; Pedreira J; Poveda E
    Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):20-26. PubMed ID: 27609631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
    Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
    Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
    Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
    AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations of HIV patients in a major Israeli HIV/AIDS center during the years 2000 to 2012.
    Mahlab-Guri K; Asher I; Bezalel-Rosenberg S; Elbirt D; Sthoeger ZM
    Medicine (Baltimore); 2017 May; 96(18):e6812. PubMed ID: 28471983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.
    Floris-Moore M; Lo Y; Klein RS; Budner N; Gourevitch MN; Moskaleva G; Schoenbaum EE
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):331-7. PubMed ID: 14600580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV patient hospitalization during the pre and post-HAART era].
    Pérez E; Toibaro JJ; Losso MH
    Medicina (B Aires); 2005; 65(6):482-8. PubMed ID: 16433473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy.
    Mayor AM; Gómez MA; Ríos-Olivares E; Hunter-Mellado RF
    Ethn Dis; 2008; 18(2 Suppl 2):S2-189-94. PubMed ID: 18646347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
    Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
    Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
    Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
    Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.